Autifony Therapeutics Limited (“Autifony”) is a clinical stage biotechnology company dedicated to developing new medicines to treat rare genetic CNS disorders by deploying its pioneering ion channel drug discovery platform.
Company Details
- Employees
- 30
- Founded
- -
- Address
- Stevenage
- in****@****ony.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- autifony.com
- Keywords
- jobs.
- HQ
- Stevenage
Autifony Therapeutics Questions
Autifony Therapeutics's website is autifony.com
Autifony Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/autifony-therapeutics
Autifony Therapeutics has
30 employees.
View email and phone details for 30
employees at Autifony Therapeutics.
Autifony Therapeutics's industry is
Biotechnology Research
Autifony Therapeutics's top competitors are
Biotiche Drug Discovery,
Orchard Therapeutics - U.s.,
Quell Therapeutics,
Stevenage Bioscience Catalyst,
Laverock Therapeutics,
Jazz Pharmaceuticals,
Mission Therapeutics,
Acousia Therapeutics Gmbh,
Antikor Biopharma Ltd,
Sound Pharmaceuticals, Inc..
Autifony Therapeutics's support email address is info@autifony.com
Autifony Therapeutics's categories are Biotechnology Research
Autifony Therapeutics's founding year is 2011
